Personalization of lipid-based oral dosage forms via filament-based 3D-printing
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Microfluidic and Capillary Electrophoresis Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. Industry 4 . 0 for pharmaceutical manufacturing : preparing for the smart factories of the future10.1016/j.ijpharm.2021.120554 ↗
2. The future of pharmaceutical manufacturing sciences10.1002/jps.24594 ↗
3. 3D printing as a promising tool in personalized medicine10.1208/s12249-020-01905-8 ↗
4. Personalized medicine - Part 1: evolution and development into theranostics
5. Practicality of 3D printed personalized medicines in therapeutics10.3389/fphar.2021.646836 ↗
6. A review on the full chain application of 3D printing technology in precision medicine
7. Drug repositioning for personalized medicine10.1186/gm326 ↗
8. A new chapter in pharmaceutical manufacturing: 3D-printed drug products10.1016/j.addr.2016.03.001 ↗
9. Re-envisioning pharmaceutical manufacturing: increasing agility for global patient access10.1016/j.xphs.2021.08.032 ↗
10. Alzoubi · 2023
11. On-demand fully customizable drug tablets via 3D printing technology for personalized medicine10.1016/j.jconrel.2020.02.046 ↗
12. 3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease10.1016/j.ijpharm.2023.123639 ↗
13. Reshaping drug development using 3D printing10.1016/j.drudis.2018.05.025 ↗
14. 3D printing: innovative solutions for patients and pharmaceutical industry10.1016/j.ijpharm.2022.122480 ↗
15. Extrusion 3D printing of paracetamol tablets from a single formulation with tunable release profiles through control of tablet geometry10.1208/s12249-018-1107-z ↗
16. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients
17. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles10.1016/j.jconrel.2015.09.028 ↗
18. Additive manufacturing of pharmaceuticals for precision medicine applications: a review of the promises and perils in implementation
19. A bibliometric analysis of 3D printing in personalized medicine research from 2012 to 202210.3390/ph16111521 ↗
20. 3D-printing of solid lipid tablets from emulsion gels
21. Pediatric-friendly chocolate-based dosage forms for the oral administration of both hydrophilic and lipophilic drugs fabricated with extrusion-based 3D printing10.1016/j.ejps.2020.105291 ↗
22. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease10.3390/biomedicines8120563 ↗
23. 3D printed tacrolimus suppositories for the treatment of ulcerative colitis10.1016/j.ajps.2020.06.003 ↗
24. A proof of concept for 3D printing of solid lipid-based formulations of poorly water-soluble drugs to control formulation dispersion kinetics
25. 3D printed multi-drug-loaded suppositories for acute severe ulcerative colitis
26. 3D printing of patient-tailored SNEDDS-based suppositories of lidocaine
27. Extrusion 3D printing of nutraceutical oral dosage forms formulated with monoglycerides oleogels and phytosterols mixtures
28. Customisable tablet printing: the development of multimaterial hot melt inkjet 3D printing to produce complex and personalised dosage forms
29. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release10.1016/j.jconrel.2017.06.025 ↗
30. Dropwise additive manufacturing of pharmaceutical products for amorphous and self emulsifying drug delivery systems10.1016/j.ijpharm.2017.04.003 ↗
31. Fused deposition modeling (FDM) of pharmaceuticals
32. Lipids and polymers in pharmaceutical technology : lifelong companions10.1016/j.ijpharm.2018.12.080 ↗
33. Practical application of 3D printing for pharmaceuticals in hospitals and pharmacies10.3390/pharmaceutics15071877 ↗
34. Mechanically promoted lipid-based filaments via composition tuning for extrusion-based 3D-printing
35. Filament-based 3D-printing of placebo dosage forms using brittle lipid-based excipients
36. PubChem Compound Summary for CID · 2023 · 3333
37. Bansal · 2024
38. 2011 · 1 · 1
39. Fabricating scalable, personalized wound dressings with customizable drug loadings via 3D printing10.1016/j.jconrel.2021.11.017 ↗
40. Release kinetics – concepts and applications
41. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing10.1016/j.ejpb.2016.08.016 ↗
42. An overview of 3D printing technologies for soft materials and potential opportunities for lipid-based drug delivery systems
43. Liwauddin · 2022
44. Investigating the effects of extrusion temperatures and material extrusion rates on FFF-printed thermoplastics10.1007/s00170-021-07850-5 ↗
45. Chain entanglements and mechanical behavior of high density polyethylene
46. Molecular structure of high melt strength polypropylene and its application to polymer design10.1016/j.polymer.2003.09.009 ↗
47. Control of polymer properties by entanglement: a review
48. An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms10.1016/j.ejpb.2022.06.013 ↗
49. Solid lipid excipients as matrix agents for sustained drug delivery
50. Controlled release of felodipine from 3D-printed tablets with constant surface area: influence of surface geometry
51. Manipulating drug release from 3D printed dual-drug loaded polypills using challenging polymer compositions10.1016/j.ijpharm.2023.122895 ↗
52. Melting point distribution analysis of globally approved and discontinued drugs: a research for improving the chance of success of drug design and discovery10.1002/open.201600015 ↗
53. Energy consumption and carbon footprint of 3D printing in pharmaceutical manufacture10.1016/j.ijpharm.2023.122926 ↗
54. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 1: screening of solid-state and physical properties of polyglycerol esters of fatty acids as advanced pharmaceutical excipients10.1016/j.ejpb.2020.01.012 ↗
55. Influence of particle size on the crystallization kinetics of amorphous felodipine powders10.1016/j.powtec.2012.02.010 ↗
56. N.M. Sanchez-ballester, B. Bataille, V. Delannoy, I. Soulairol, Fused deposition modelling 3D printing and solubility improvement of BCS II and IV active ingredients – a narrative review, 365 (2024) 507–520. https://doi.org/10.1016/j.jconrel.2023.11.041.10.1016/j.jconrel.2023.11.041 ↗
57. Mechanisms of increased bioavailability through amorphous solid dispersions: a review10.1080/10717544.2019.1704940 ↗
58. Effect of hydrogen bond formation /replacement on solubility characteristics , gastric permeation and pharmacokinetics of curcumin by application of powder solution technology10.1016/j.apsb.2016.05.015 ↗
59. Solid-state characterization of Felodipine-SoluplusⓇ amorphous solid dispersions10.3109/03639045.2015.1104347 ↗
60. Hot melt extrausion assisted felodipine loaded liquid crystal precursor with enhanced solubility and sustained drug release characteristics10.1080/22297928.2022.2159523 ↗
61. Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets10.1081/DDC-120003007 ↗
62. Channelled tablets: an innovative approach to accelerating drug release from 3D printed tablets10.1016/j.jconrel.2017.11.022 ↗
63. Novel on-demand 3-dimensional (3-d) printed tablets using fill density as an effective release-controlling tool10.3390/polym12091872 ↗
64. Development of controlled release oral dosages by density gradient modification via three-dimensional (3D) printing and hot-melt extrusion (HME) technology
65. Patel · 2021 · 600
66. 3D printed oral solid dosage form : modified release and improved solubility10.1016/j.jconrel.2022.09.023 ↗
67. Modified release from hydroxypropyl methylcellulose compression-coated tablets10.1016/j.ijpharm.2010.09.021 ↗
68. Hydroxy propyl methyl cellulose: different aspects in drug delivery
69. 2009 · 1
70. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 2: application of polyglycerol esters of fatty acids as hot melt coating excipients10.1016/j.ejpb.2020.01.009 ↗
71. Polyglycerol esters of fatty acids as safe and stable matrix forming tableting excipients : a structure-function analysis